Healthcare

This issue of Vital Signs, released on April 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.

This research service analyzes the US general X-ray radiography imaging equipment market, which is transitioning toward more compact portable and modular digital technologies. The market segments evaluated are analog radiography, computed radiography (CR), and digital radiography (DR). The suites, mobiles, and retrofits sub-segments of the DR segme...

The research service titled Top Medical Device and Imaging Technologies, is an update on the study done in the past year (D2F9 Top Medical Device and Imaging Technologies) that showcased medical technologies on the cusp of commercialization, both device and imaging centric, which hold the potential to possibly revolutionize the healthcare landsca...

This research service pertains to the US market for interventional x-ray equipment used in radiology and cardiology. A thorough market sizing and forecasting model of market revenue, unit shipments, and pricing is included, along with analyses of technology trends, market drivers and restraints, and the competitive environment. The two market segme...

This study provides a roadmap for understanding the hospital revenue management (RCM) market. Herein Frost & Sullivan provides an in-depth overview of the market including major government initiatives driving changes in the market, defines and describes major market segments including technology solutions and services used by hospitals, discusses t...

This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due to a period of patent expirations, competitive expansion, and pricing pressure. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive lands...

This issue of Vital Signs, released on March 28, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.

This market engineering research service evaluates the U.S. left ventricular assist devices (LVAD) market. This analysis presents an overview of the market, identifying key drivers and restraints. Furthermore, it outlines market engineering measurements and market opportunities, while also providing a market share analysis and strategic recommendat...

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies. Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.